79 related articles for article (PubMed ID: 1324793)
1. Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin Cł.
Malkinson AM; Siegel D; Forrest GL; Gazdar AF; Oie HK; Chan DC; Bunn PA; Mabry M; Dykes DJ; Harrison SD
Cancer Res; 1992 Sep; 52(17):4752-7. PubMed ID: 1324793
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of non-small cell lung cancer cell lines resistant to mitomycin C under aerobic conditions.
Shibata K; Kasahara K; Bando T; Nakatsumi Y; Fujimura M; Tsuruo T; Matsuda T
Jpn J Cancer Res; 1995 May; 86(5):460-9. PubMed ID: 7790319
[TBL] [Abstract][Full Text] [Related]
3. Tumor-overexpressed enzyme responsive amphiphiles small molecular self-assembly nano-prodrug for the chemo-phototherapy against non-small-cell lung cancer.
Liu P; Huang Y; Zhan C; Zhang F; Deng C; Jia Y; Wan T; Wang S; Li B
Mater Today Bio; 2023 Aug; 21():100722. PubMed ID: 37545562
[TBL] [Abstract][Full Text] [Related]
4. A highly selective fluorescent probe for human NAD(P)H:quinone oxidoreductase 1 (hNQO1) detection and imaging in living tumor cells.
Zhu Y; Han J; Zhang Q; Zhao Z; Wang J; Xu X; Hao H; Zhang J
RSC Adv; 2019 Aug; 9(46):26729-26733. PubMed ID: 35528556
[TBL] [Abstract][Full Text] [Related]
5. Quinone oxidoreductase 1 is overexpressed in gastric cancer and associated with outcome of adjuvant chemotherapy and survival.
Jiang ZN; Ahmed SMU; Wang QC; Shi HF; Tang XW
World J Gastroenterol; 2021 Jun; 27(22):3085-3096. PubMed ID: 34168410
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of wild-type p53 by small molecule-induced elevation of NQO1 in non-small cell lung cancer cells.
Yu H; Gao HY; Guo H; Wang GZ; Yang YQ; Hu Q; Liang LJ; Zhao Q; Xie DW; Rao Y; Zhou GB
Acta Pharmacol Sin; 2022 Mar; 43(3):692-702. PubMed ID: 34035487
[TBL] [Abstract][Full Text] [Related]
7. Succinylation-dependent mitochondrial translocation of PKM2 promotes cell survival in response to nutritional stress.
Qi H; Ning X; Yu C; Ji X; Jin Y; McNutt MA; Yin Y
Cell Death Dis; 2019 Feb; 10(3):170. PubMed ID: 30787272
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-targeted drug delivery.
Sharma A; Arambula JF; Koo S; Kumar R; Singh H; Sessler JL; Kim JS
Chem Soc Rev; 2019 Feb; 48(3):771-813. PubMed ID: 30575832
[TBL] [Abstract][Full Text] [Related]
9. Development of novel amino-quinoline-5,8-dione derivatives as NAD(P)H:quinone oxidoreductase 1 (NQO1) inhibitors with potent antiproliferative activities.
Ling Y; Yang QX; Teng YN; Chen S; Gao WJ; Guo J; Hsu PL; Liu Y; Morris-Natschke SL; Hung CC; Lee KH
Eur J Med Chem; 2018 Jun; 154():199-209. PubMed ID: 29803003
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological implications of NQO1 overexpression in the prognosis of pancreatic adenocarcinoma.
Ji M; Jin A; Sun J; Cui X; Yang Y; Chen L; Lin Z
Oncol Lett; 2017 May; 13(5):2996-3002. PubMed ID: 28521407
[TBL] [Abstract][Full Text] [Related]
11. Reactive Oxygen Species Synergize To Potently and Selectively Induce Cancer Cell Death.
Lee HY; Parkinson EI; Granchi C; Paterni I; Panigrahy D; Seth P; Minutolo F; Hergenrother PJ
ACS Chem Biol; 2017 May; 12(5):1416-1424. PubMed ID: 28345875
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent isobutyl-deoxynyboquinone (IB-DNQ), a NQO1 bioactivatable molecule, in the domestic felid species.
Lundberg AP; Francis JM; Pajak M; Parkinson EI; Wycislo KL; Rosol TJ; Brown ME; London CA; Dirikolu L; Hergenrother PJ; Fan TM
Invest New Drugs; 2017 Apr; 35(2):134-144. PubMed ID: 27975234
[TBL] [Abstract][Full Text] [Related]
13. Enhancing Oral Absorption of β-Lapachone: Progress Till Date.
Bermejo M; Mangas-Sanjuan V; Gonzalez-Alvarez I; Gonzalez-Alvarez M
Eur J Drug Metab Pharmacokinet; 2017 Feb; 42(1):1-10. PubMed ID: 27538882
[TBL] [Abstract][Full Text] [Related]
14. Implications of NQO1 in cancer therapy.
Oh ET; Park HJ
BMB Rep; 2015 Nov; 48(11):609-17. PubMed ID: 26424559
[TBL] [Abstract][Full Text] [Related]
15. NQO1 Stabilizes p53 in Response to Oncogene-Induced Senescence.
Liu K; Jin B; Wu C; Yang J; Zhan X; Wang L; Shen X; Chen J; Chen H; Mao Z
Int J Biol Sci; 2015; 11(7):762-71. PubMed ID: 26078718
[TBL] [Abstract][Full Text] [Related]
16. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
[TBL] [Abstract][Full Text] [Related]
17. The Tumor-Selective Cytotoxic Agent β-Lapachone is a Potent Inhibitor of IDO1.
Flick HE; Lalonde JM; Malachowski WP; Muller AJ
Int J Tryptophan Res; 2013; 6():35-45. PubMed ID: 24023520
[TBL] [Abstract][Full Text] [Related]
18. Lack of association between NADPH quinone oxidoreductase 1 (NQO1) gene C609T polymorphism and lung cancer: a case-control study and a meta-analysis.
Guo S; Gao M; Li X; Li Y; Chu S; Zhu D; Niu W
PLoS One; 2012; 7(10):e47939. PubMed ID: 23110137
[TBL] [Abstract][Full Text] [Related]
19. Quinone-induced activation of Keap1/Nrf2 signaling by aspirin prodrugs masquerading as nitric oxide.
Dunlap T; Piyankarage SC; Wijewickrama GT; Abdul-Hay S; Vanni M; Litosh V; Luo J; Thatcher GR
Chem Res Toxicol; 2012 Dec; 25(12):2725-36. PubMed ID: 23035985
[TBL] [Abstract][Full Text] [Related]
20. An NQO1-initiated and p53-independent apoptotic pathway determines the anti-tumor effect of tanshinone IIA against non-small cell lung cancer.
Liu F; Yu G; Wang G; Liu H; Wu X; Wang Q; Liu M; Liao K; Wu M; Cheng X; Hao H
PLoS One; 2012; 7(7):e42138. PubMed ID: 22848731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
